Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitals.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
05 07 2021
Historique:
entrez: 15 7 2021
pubmed: 16 7 2021
medline: 21 10 2021
Statut: epublish

Résumé

Optimal surveillance and prevention of healthcare-associated infections (HAI) are crucial for a well-functioning health care system. With a view to establishing a national state-of-the-art programme for surveillance and prevention of HAIs, the Swiss National Center for Infection Control, Swissnoso, developed a survey to explore the options for expanding the existing Swiss HAI surveillance system. An online survey was sent to all Swiss acute care hospitals. Local infection prevention and control (IPC) professionals were asked to answer on behalf of their institutions. The questions covered the structure and organisation of IPC programmes, current preventive measures, availability and capacity of electronic medical record (EMR) systems, and ability and willingness to establish and participate in the proposed new surveillance modules. An invitation was sent to the 156 acute care hospitals and hospital networks in June 2020. Responses were collected up to the end of August 2020. Ninety-four hospitals and hospital networks out of 156 (60%) completed the survey. Among 84 hospitals reporting the number of acute care beds, 61 (73%) were small (<200 beds), 16 (19%) medium (200–650 beds) and 7 (8%) large hospitals (>650 beds). Twenty-nine different EMR systems were used in the participating hospitals. Twenty-two hospitals were using a different EMR system in their intensive care unit. There were 17 hospitals (18%) without an EMR system but which planned to introduce one soon, and eight small hospitals (9%) neither had an EMR system nor were preparing to introduce one. Surveillance for central-line associated bloodstream infection, catheter-associated urinary tract infection and ventilator-associated pneumonia were already established in 26 (28%), 15 (16%) and 15 (16%) hospitals, respectively. Thirty hospitals (36%) would be willing to participate in the pilot phase of a new surveillance system. Of these, 15 stated that they wanted to be part of the pilot hospital network, 6 could provide hospital-wide surveillance denominators (such as catheter-days and patient-days) to compute incidence rates, and 8 indicated interest in doing both. Large hospitals interested in participating in the pilot phase reported more full-time equivalent staff available for surveillance activities than those who did not declare an interest. Baseline information on hospital IPC structure and process indicators are essential for the roll-out of national surveillance programmes and for improving surveillance activities. Having an EMR system in place and adequate personnel resources dedicated for surveillance activities are crucial prerequisites for developing and implementing an effective HAI surveillance system. The lack of an EMR system and the diversity and capacities of EMR solutions will be the main challenges for successful implementation of national HAI surveillance modules.

Identifiants

pubmed: 34265072
doi: 10.4414/smw.2021.20516
pii: Swiss Med Wkly. 2021;151:w20516
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20516

Investigateurs

Carlo Balmelli (C)
Marie-Christine Eisenring (MC)
Stephan Harbarth (S)
Jonas Marschall (J)
Didier Pittet (D)
Hugo Sax (H)
Matthias Schlegel (M)
Alexander Schweiger (A)
Laurence Senn (L)
Rami Sommerstein (R)
Nicolas Troillet (N)
Sarah Tschudin-Sutter (S)
Danielle Vuichard-Gysin (D)
Andreas Widmer
Giorgio Zanetti (G)
Walter Zingg (W)

Commentaires et corrections

Type : ErratumIn

Auteurs

Aliki Metsini (A)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland / Cantonal Physician Office, Canton of Geneva, Switzerland.

Andreas Widmer (A)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland / Division of Infectious diseases and Hospital Epidemiology, University of Basel Hospitals and Clinics, Basel, Switzerland.

Walter Zingg (W)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland / Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.

Céline Gardiol (C)

Federal Office of Public Health, Bern, Switzerland.

Danielle Vuichard-Gysin (D)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland / Division of Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, Switzerland.

Marcus Eder (M)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland.

Judith Maag (J)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland.

Matthias Schlegel (M)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland / Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Switzerland.

Jonas Marschall (J)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland / Department of Infectious Diseases, Bern University Hospital, University of Bern, Switzerland.

Stephan Harbarth (S)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland / Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Rami Sommerstein (R)

Swissnoso, Swiss Centre for Infection Prevention, Bern, Switzerland / Department of Infectious Diseases, Bern University Hospital, University of Bern, Switzerland / Infectious Diseases, Hirslanden Central Switzerland, Lucerne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH